Más de 1.000 pacientes se inscriben en un estudio histórico de SELUTION DeNovo

Posted on by

GINEBRA, 16 de marzo de 2023 /PRNewswire/ — MedAlliance ha anunciado el reclutamiento de más de 1.000 pacientes en su innovador estudio coronario aleatorizado SELUTION DeNovo. Ya se ha completado un tercio del reclutamiento para alcanzar el objetivo de 3.326 pacientes. SELUTION DeNovo…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.